Related references
Note: Only part of the references are listed.Activin A Promotes Regulatory T-cell-Mediated Immunosuppression in Irradiated Breast Cancer
Mara De Martino et al.
CANCER IMMUNOLOGY RESEARCH (2021)
Immunologic Cold Squamous Cell Carcinomas of the Head and Neck Are Associated With an Unfavorable Prognosis
Julika Ribbat-Idel et al.
FRONTIERS IN MEDICINE (2021)
Combinations of Radiotherapy with Vaccination and Immune Checkpoint Inhibition Differently Affect Primary and Abscopal Tumor Growth and the Tumor Microenvironment
Michael Rueckert et al.
CANCERS (2021)
(Chemo)Radiotherapy-Immunotherapy Combinations: Time to Get Tailored?
Michele Mondini et al.
CLINICAL CANCER RESEARCH (2021)
Heterogeneity of IFN-Mediated Responses and Tumor Immunogenicity in Patients with Cervical Cancer Receiving Concurrent Chemoradiotherapy
Jianzhou Chen et al.
CLINICAL CANCER RESEARCH (2021)
Radiotherapy and the immune system: More than just immune suppression
Michael Ruckert et al.
STEM CELLS (2021)
Lichen planus related to transforming growth factor beta inhibitor in a patient with metastatic chondrosarcoma: a case report
Maya Farah et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2020)
TGF-β in radiotherapy: Mechanisms of tumor resistance and normal tissues injury
Bagher Farhood et al.
PHARMACOLOGICAL RESEARCH (2020)
TGF-beta: a master immune regulator
Christopher Larson et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2020)
NK Cell Function Regulation by TGF-β-Induced Epigenetic Mechanisms
Stefano Regis et al.
FRONTIERS IN IMMUNOLOGY (2020)
Selective inhibition of TGFβ1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape
Constance J. Martin et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
TGFβ suppresses CD8+ T cell expression of CXCR3 and tumor trafficking
Andrew J. Gunderson et al.
NATURE COMMUNICATIONS (2020)
Differential therapeutic effects of PARP and ATR inhibition combined with radiotherapy in the treatment of subcutaneous versus orthotopic lung tumour models
Vanessa Tran Chau et al.
BRITISH JOURNAL OF CANCER (2020)
Dual oxidase 1 limits the IFNγ-associated antitumor effect of macrophages
Lydia Meziani et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Turning up the heat on non-immunoreactive tumours: opportunities for clinical development
María Ochoa de Olza et al.
LANCET ONCOLOGY (2020)
The Impact of Radiation-Induced DNA Damage on cGAS-STING-Mediated Immune Responses to Cancer
Quinn Storozynsky et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Dissimilar patterns of tumor-infiltrating immune cells at the invasive tumor front and tumor center are associated with response to neoadjuvant chemotherapy in primary breast cancer
Lisa Koenig et al.
BMC CANCER (2019)
TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination with Anti-PD1 and Anti-CD137 Immunostimulatory Monoclonal Antibodies
Maria E. Rodriguez-Ruiz et al.
MOLECULAR CANCER THERAPEUTICS (2019)
CCR2-Dependent Recruitment of Tregs and Monocytes Following Radiotherapy Is Associated with TNFα-Mediated Resistance
Michele Mondini et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Transforming Growth Factor-β Signaling in Immunity and Cancer
Eduard Batlle et al.
IMMUNITY (2019)
TGFβ blocks IFNα/β release and tumor rejection in spontaneous mammary tumors
Marion V. Guerin et al.
NATURE COMMUNICATIONS (2019)
TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
Daniele V. F. Tauriello et al.
NATURE (2018)
Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment
Elisa Peranzoni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
TGF-β in T Cell Biology: Implications for Cancer Immunotherapy
Amina Dahmani et al.
CANCERS (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
Topography of cancer-associated immune cells in human solid tumors
Jakob Nikolas Kather et al.
ELIFE (2018)
Tumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma
Anusha Kalbasi et al.
CLINICAL CANCER RESEARCH (2017)
Immune recognition of irradiated cancer cells
Erik Wennerberg et al.
IMMUNOLOGICAL REVIEWS (2017)
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
Claire Vanpouille-Box et al.
NATURE COMMUNICATIONS (2017)
Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer
Sotirios P. Fortis et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
A phase 1 study of anti-TGFβ receptor type-II monoclonal antibody LY3022859 in patients with advanced solid tumors
Anthony W. Tolcher et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
M-CSF and GM-CSF Receptor Signaling Differentially Regulate Monocyte Maturation and Macrophage Polarization in the Tumor Microenvironment
Eva Van Overmeire et al.
CANCER RESEARCH (2016)
Immunoregulation by members of the TGFβ superfamily
WanJun Chen et al.
NATURE REVIEWS IMMUNOLOGY (2016)
TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity
Claire Vanpouille-Box et al.
CANCER RESEARCH (2015)
DNA Damage Primes the Type I Interferon System via the Cytosolic DNA Sensor STING to Promote Anti-Microbial Innate Immunity
Anetta Hartlova et al.
IMMUNITY (2015)
Synergy of Radiotherapy and a Cancer Vaccine for the Treatment of HPV-Associated Head and Neck Cancer
Michele Mondini et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Type I interferons in anticancer immunity
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Neutralizing Murine TGFβR2 Promotes a Differentiated Tumor Cell Phenotype and Inhibits Pancreatic Cancer Metastasis
Katherine T. Ostapoff et al.
CANCER RESEARCH (2014)
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
Liufu Deng et al.
IMMUNITY (2014)
TGFβ Inhibition Prior to Hypofractionated Radiation Enhances Efficacy in Preclinical Models
Kristina H. Young et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Neuroblastoma-Derived TGF-β1 Modulates the Chemokine Receptor Repertoire of Human Resting NK Cells
Roberta Castriconi et al.
JOURNAL OF IMMUNOLOGY (2013)
Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift
Silvia C. Formenti et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Blockade of TGF-β Signaling by the TGFβR-I Kinase Inhibitor LY2109761 Enhances Radiation Response and Prolongs Survival in Glioblastoma
Mengxian Zhang et al.
CANCER RESEARCH (2011)
Blockade of Tumor Necrosis Factor α Signaling in Tumor-Associated Macrophages as a Radiosensitizing Strategy
Yuru Meng et al.
CANCER RESEARCH (2010)
Anti-Transforming Growth Factor β Receptor II Antibody Has Therapeutic Efficacy against Primary Tumor Growth and Metastasis through Multieffects on Cancer, Stroma, and Immune Cells
Zhaojing Zhong et al.
CLINICAL CANCER RESEARCH (2010)
A critical function for TGF-β signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells
Yongzhong Liu et al.
NATURE IMMUNOLOGY (2008)
Share Paper
